“The Capture of Academia: How Universities Shape Power, Silence Dissent, and Influence Society“ trialsitenews.com/a/the-capt…

More expensive. More advanced. But better for patients? A Phase III liver cancer trial found proton therapy failed to improve survival over conventional radiation. 2-year survival: 56.2% vs. 69.3%. Not statistically significant—but a wake-up call. trialsitenews.com/a/proton-t…

23% weight loss. Up to 27% quit due to side effects. Eli Lilly's experimental triple-action diabetes treatment delivers remarkable results—but at what cost? Is Big Pharma chasing better patient outcomes or bigger weight-loss numbers? trialsitenews.com/a/lillys-t…

SOUTH KOREA'S NURSING-HOME DEATH SURGE. Nearly 7,000 estimated excess deaths during 2020–2022—most in 2022, AFTER mass COVID vaccination. But researchers lacked individual vaccination records. Omicron? Disrupted care? Other causes? What about the vaccines? trialsitenews.com/a/south-ko…

VACCINE TRIAL BOMBSHELL. 90% of surveyed future European healthcare professionals support vaccination. Yet just 33% would volunteer for a future vaccine trial. Among those unsure or unwilling, 75% cited side-effect concerns. trialsitenews.com/a/vaccine-…

Do childhood vaccines cause autism? Dr. Mastrangelo challenges decades of research. But do his claims survive scrutiny? Big Pharma deserves tough questions. So do vaccine critics. Families deserve evidence—not institutional spin or unproven theories. trialsitenews.com/a/do-child…

Google’s medical AI passed an early real-world test: 98 patient encounters, zero safety stops. But here’s the catch: A physician monitored EVERY conversation. Alphabet funded the study. Promising technology—or premature hype? TrialSite News investigates. trialsitenews.com/a/googles-…

PFIZER’S ARGENTINA TRIAL: 52 volunteers given nearly DOUBLE the intended COVID vaccine dose. 20 regulatory findings. Placebo assigned. Active vaccine administered. Lead investigator held financial interests in the trial administrator. trialsitenews.com/a/pfizers-…

1,009 Studies on EMF Harm. Is Washington Finally Listening? RFK Jr. wants answers. MAHA influencer Sayer Ji points to alarming research. But major human studies tell a more reassuring story—while animal cancer findings raise serious questions. trialsitenews.com/a/emf-and-…

Can Your Blood Reveal How Fast You're Aging?Scientists analyzed 12.4 MILLION immune cells and identified a signature linked to chronic disease and early death. A breakthrough in longevity science—or an unproven biomarker? trialsitenews.com/a/study-of…

A potential breakthrough—or a dangerous gamble? Washington is accelerating psychedelic research, but ibogaine carries serious cardiac risks. Patients deserve innovation. Science must prove safety and efficacy. trialsitenews.com/a/fda-open…

14,000 African newborns. Four ethics committee resignations. $1.6M in U.S. funding. The Guinea-Bissau hepatitis B trial exposes a dangerous fault line between scientific freedom and medical ethics. Why not an observational study? trialsitenews.com/a/guinea-b…

MAHA won a seat at the table. Can patients get through the clinic door? Kennedy faces demands for care, calls to pull mRNA shots—and Democrats courting his voters. A ribbon cutting buys headlines. Will accessible care arrive before Election Day? trialsitenews.com/a/mahas-br…

273 DEATH REPORTS. 877 SERIOUS ADVERSE EVENT REPORTS. A new CDC study examines nearly 10,000 reports following 2024–25 COVID-19 vaccination. VAERS cannot prove causation—but can it reliably detect rare risks? trialsitenews.com/a/cdc-vacc…

Denmark’s vaccine-injured patients aren’t imaginary. In a remarkable meeting, SSI officials acknowledged their EFTER-COVID study cannot rule out rare, serious vaccine injuries—yet patients say its reassuring findings have helped justify a system offering them little investigation

Dr. Mary Talley Bowden tells TrialSite News the movement that fought COVID mandates and helped create the political force behind RFK Jr. and Trump is now being overshadowed by MAHA. Our interview with @MdBreathe Dr. Mary Talley Bowden trialsitenews.com/a/we-have-…

Diabetes drug may be doing more than lowering blood sugar. A Vanderbilt human study found empagliflozin reduced inflammatory cell clusters linked to cardiovascular disease within just 2 weeks—with a stronger effect by week 12. trialsitenews.com/a/popular-…

University of Chicago researchers transplanted donor insulin-producing islet cells using an experimental tegoprubart-based anti-rejection regimen. Remarkable early signal—but not yet a cure. The big questions: durability, immunosuppression and scalability. trialsitenews.com/a/12-of-12…

China isn’t just making cheaper drugs anymore. It is building the entire biopharma innovation machine. Now radiopharmaceuticals are accelerating: Lu-177, PSMA, FAP, Trop2, HER2, CLDN18.2—plus domestic isotope production, PET technology and expanding clinical pipelines.

A striking health number from 2025: America’s age-adjusted death rate fell 4.6% to 689.2 deaths per 100,000—the lowest ever recorded, according to provisional CDC data. It happened during the first year of the Trump administration and Robert F. Kennedy Jr.’s tenure at HHS.

California says Washington is politicizing science—so it wants voters to borrow $7.5 BILLION to build its own research-funding machine. The case FOR: protect scientists from ideological federal grant cuts. The case AGAINST: why assume Sacramento won’t politicize science too?